Resilience in patients with recent diagnosis of a schizophrenia spectrum disorder

Journal of Nervous and Mental Disease

Volumn 204, Issue 8, 2016, Pages 578-584

  Bozikas, Vasilis P ^a   Parlapani, Eleni ^a   Holeva, Vasiliki ^a   Skemperi, Eleni ^a   Bargiota, Stavroula I ^a   Kirla, Danai ^a   Rera, Eirini ^a   Garyfallos, Georgios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Hopelessness; Resilience; Schizophrenia spectrum disorders

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; HALOPERIDOL; LONG ACTING DRUG; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BECK HOPELESSNESS SCALE; BRIEF PSYCHOTIC DISORDER; CALGARY DEPRESSION SCALE; CLINICAL ARTICLE; CONNOR DAVIDSON RESILIENCE SCALE; CONTROLLED STUDY; COPING BEHAVIOR; DELUSIONAL DISORDER; DEPRESSION; FEMALE; HOPELESSNESS; HUMAN; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PSYCHOMETRY; PSYCHOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; PATHOPHYSIOLOGY; PSYCHOLOGICAL RESILIENCE; PSYCHOLOGY;

ADULT; FEMALE; HUMANS; MALE; RESILIENCE, PSYCHOLOGICAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84974670725     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0000000000000541     Document Type: Article

References (70)

1. Abel KM, Drake R, Goldstein JM (2010) Sex differences in schizophrenia. Int Rev Psychiatry. 22:417-428.
2. Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: The Calgary Depression Scale. Br J Psychiatry Suppl. 22:39-44.
3. Agaibi CE, Wilson JP (2005) Trauma, PTSD, and resilience: A reviewof the literature. Trauma Violence Abuse. 6:195-216.
4. Aguilar EJ, Haas G, Manzanera FJ, Hernández J, Gracia R, Rodado MJ, Keshavan MS (1997) Hopelessness and first-episode psychosis: A longitudinal study. Acta Psychiatr Scand. 96:25-30.
5. Álvarez-Jiménez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Killackey E, Bendall S, Amminger GP, Yung AR, Herrman H, Jackson HJ, McGorry PD (2012) Road to full recovery: Longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med 42: 595-606.
6. Andresen R, Oades L, Caputi P (2003) The experience of recovery from schizophrenia: Towards an empirically validated stage model. Aust N Z J Psychiatry. 37: 586-594.
7. Beck AT, Weissman A, Lester D, Trexler L (1974) The measurement of pessimism: The hopelessness scale. J Consult Clin Psychol. 42:861-865.
8. Benard B (2004) Resilience outcomes: Personal strengths. In Benard B (Ed), Resiliency: What we have learned (pp 13-35). San Francisco: West Ed.
9. Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 172:53-59.
10. Bitsika V, Sharpley CF, Peters K (2010) How is resilience associated with anxiety and depression? Analysis of factor score interactions within a homogeneous sample. German J Psychiatry. 13:9-16.
11. Bolier L, Haverman M, Westerhof GJ, Riper H, Smit F, Bohlmeijer E (2013) Positive psychology interventions: a meta-analysis of randomized controlled studies. BMC Public Health. 13:119.
12. Bosanac P, Castle DJ (2012) Schizophrenia and depression. MJA Open. 1:36-39.
13. Buckley PF, Stahl SM (2007) Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Acta Psychiatr Scand. 115:93-100.
14. Campellone TR, Caponigro JM, Kring AM (2014) The power to resist: the relationship between power, stigma, and negative symptoms in schizophrenia. Psychiatry Res. 215:280-285.
15. Carpenter WT Jr, Strauss JS (1991) The prediction of outcome in schizophrenia. IV: Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis. 179: 517-525.
16. CD-RISC. The Connor-Davidson Resilience Scale. Available at: http://www.connordavidson-resiliencescale.com. Accessed on September 14, 2015.
17. Choi JW, Cha B, Jang J, Park CS, Kim BJ, Lee CS, Lee SJ (2015) Resilience and impulsivity in euthymic patientswith bipolar disorder. J Affect Disord. 170:172-177.
18. Connor KM, Davidson JR (2003)Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 18:76-82.
19. Cotton SM, Lambert M, Schimmelmann BG, Foley DL, Morley KI, McGorry PD, Conus P (2009) Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res. 114:17-24.
20. Davis LW, Nees MA, Hunter NL, Lysaker PH (2004) Hopelessness as a predictor of work functioning among patients with schizophrenia. Psychiatr Serv. 55:434-436.
21. Díaz-Caneja CM, Pina-Camacho L, Rodríguez-Quiroga A, Fraguas D, Parellada M, Arango C (2015) Predictors of outcome in early-onset psychosis: A systematic review. NPJ Schizophr. 1:14005.
22. Dimitriadou D, Stalikas A (2012) Connor-Davidson Resilience Scale (CD-RISC). In Stalikas A, Triliva S, Roussi P (Eds), Psychometric instruments in Greece (2nd ed, p 717). Athens, Greece: Pedio.
23. Gable SL, Haidt J (2005)What (and why) is positive psychology? Rev Gen Psychol. 9: 103-110.
24. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010) International consensus study of antipsychotic dosing. Am J Psychiatry. 167:686-693.
25. Goldman HH, Skodol AE, Lave TR (1992) Revising axis V for DSM-IV: A review of measures of social functioning. Am J Psychiatry. 149:1148-1156.
26. Guy W (1976) The Clinical Global Impression Scale. In ECDEU assessment manual for psychopharmacology-revised (pp 218-222). Rockville, MD: US Department of Health, Education and Welfare, ADAMHA, MIMH Psychopharmacology Research Branch.
27. Harrow M, Jobe TH (2007) Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year multifollow-up study. J Nerv Ment Dis. 195:406-414.
28. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ (2005) Schizophrenia and suicide: Systematic review of risk factors. Br J Psychiatry. 187:9-20.
29. Henderson AR, Cock A (2015) The responses of young people to their experiences of first-episode psychosis: Harnessing resilience. Community Ment Health J. 51: 322-328.
30. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III-The final common pathway. Schizophr Bull. 35:549-562.
31. Johnson J, Gooding PA, Wood AM, Taylor PJ, Pratt D, Tarrier N (2010) Resilience to suicidal ideation in psychosis: Positive self-appraisals buffer the impact of hopelessness. Behav Res Ther. 48:883-889.
32. Kane JM, Leucht S, Carpenter D, Docherty JP (2003) Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 64:5-19.
33. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:261-276.
34. Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, Kang JI, Lee E, Yoo SW, An SK, Kwon JS (2013) The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 47:762-771.
35. Kontaxakis VP, Havaki-Kontaxaki BJ, Margariti MM, Stamouli SS, Kollias CT, Angelopoulos EK, Christodoulou GN (2000) The Greek version of the Calgary Depression Scale for Schizophrenia. Psychiatry Res. 94:163-171.
36. Kundu PS, Sinha VK, Paul SE, Desarkar P (2013) Current social functioning in adultonset schizophrenia and its relation with positive symptoms. Ind Psychiatry J. 22: 65-68.
37. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 20:687-702.
38. Lieberman JA, Stroup TS, McEvoy JP, Swarz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl JMed. 353:1209-1223.
39. Lykouras E, Botsis A, Oulis P (Eds) (1994) The positive and negative syndrome scale (PANSS) [in Greek]. Athens, Greece: Tsiveriotis Ed.
40. Lysaker PH, Salyers MP, Tsai J, Spurrier LY, Davis LW(2008) Clinical and psychological correlates of two domains of hopelessness in schizophrenia. J Rehabil Res Dev. 45:911-919.
41. Malla A, Payne J (2005) First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull. 31:650-671.
42. Mann CJ (2003) Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 20:54-60.
43. Marulanda S, Addington J (2014) Resilience in individuals at clinical high risk for psychosis. Early Interv Psychiatry. 10:212-219.
44. Messias EL, Chen CY, Eaton WW (2007) Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am. 30:323-338.
45. Meyer PS, Johnson DP, Parks A, Iwanski C, Penn DL (2012) Positive living: A pilot study of group positive psychotherapy for people with schizophrenia. J Positive Psychol. 7:239-248.
46. Millier A, Schmidt U, Angermeyer MC, Chauhan D, Murthy V, Toumi M, Cadi-Soussi N (2014) Humanistic burden in schizophrenia: A literature review. J Psychiatr Res. 54:85-93.
47. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Hatzipli I, Galanos A, Vlahos L (2008) The experience of hopelessness in a population of Greek cancer patients receiving palliative care. Int J Soc Psychiatry. 54:262-271.
48. Palmer BW, Martin AS, Depp CA, Glorioso DK, Jeste DV (2014)Wellness within illness: Happiness in schizophrenia. Schizophr Res. 159:151-156.
49. Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: Systematic review and meta-analysis. Br J Psychiatry. 205:88-94.
50. Resnick SG, Rosenheck RA (2006) Recovery and positive psychology: Parallel themes and potential synergies. Psychiatr Serv. 57:120-122.
51. Roberts G, Boardman J (2013) Understanding "recovery". Adv Psychiatr Treat. 19: 400-409.
52. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59:22-33; quiz 34-57.
53. Sheldon KM, King L (2001) Why positive psychology is necessary. Am Psychol. 56: 216-217.
54. Sibitz I, Unger A, Woppmann A, Zidek T, Amering M(2011) Stigma resistance in patients with schizophrenia. Schizophr Bull. 37:316-323.
55. Sin NL, Lyubomirsky S (2009) Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: A practice-friendly metaanalysis. J Clin Psychol. 65:467-487.
56. Southwick SM, Bonanno GA, Masten AS, Panter-Brick C, Yehuda R (2014) Resilience definitions, theory, and challenges: interdisciplinary perspectives. Eur J Psychotraumatol. 5:1-14.
57. Southwick SM, Vythilingam M, Charney DS (2005) The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annu Rev Clin Psychol. 1:255-291.
58. Stouten LH, Veling W, Laan W, van der Helm M, van der Gaag M (2014) Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis. Schizophr Res. 158: 113-119.
59. Tandon R, Keshavan MS, Nasrallah HA (2008) Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 102:1-18.
60. Tandon R, Nasrallah HA, Keshavan MS(2009) Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res. 110:1-23.
61. Thompson KN, McGorry PD, Harrigan SM (2003) Recovery style and outcome in first-episode psychosis. Schizophr Res. 62:31-36.
62. Torgalsbøen AK (2012) Sustaining full recovery in schizophrenia after 15 years: does resilience matter? Clin Schizophr Relat Psychoses. 5:193-200.
63. Upthegrove R (2009) Depression in schizophrenia and early psychosis: Implications for assessment and treatment. Adv Psychiatr Treat. 15:372-379.
64. Vaishnavi S, Connor K, Davidson JR (2007) An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: Psychometric properties and applications in psychopharmacological trials. Psychiatry Res. 152:293-297.
65. White RG, McCleery M, Gumley AI, Mulholland C (2007) Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness. J Nerv Ment Dis. 195:968-975.
66. Windle G, Bennett KM, Noyes J (2011) A methodological review of resilience measurement scales. Health Qual Life Outcomes. 9:8.
67. Wingo AP, Ressler KJ, Bradley B (2014) Resilience characteristics mitigate tendency for harmful alcohol and illicit drug use in adults with a history of childhood abuse: A cross-sectional study of 2024 inner-city men andwomen. J Psychiatr Res. 51:93-99.
68. Wong MM, Nigg JT, Zucker RA, Puttler LI, Fitzgerald HE, Jester JM, Glass JM, Adams K (2006) Behavioral control and resiliency in the onset of alcohol and illicit drug use: A prospective study from preschool to adolescence. Child Dev. 77: 1016-1033.
69. Wright O'Dougherty M, Masten AS, Narayan AJ (2013) Resilience processes in development: Four waves of research on positive adaptation in the context of adversity. In Goldstein S, Brooks RB (Eds), Handbook of resilience in children (pp 15-37). New York: Springer Science and Business Media.
70. Ziaian T, de Anstiss H, Antoniou G, Baghurst P, Sawyer M (2012) Resilience and its association with depression, emotional and behavioural problems, and mental health service utilisation among refugee adolescents living in South Australia. Int J Population Res. 1-9. doi:10.1155/2012/485956.